ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 205.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $23,000 | +4.5% | 10,730 | +0.6% | 0.00% | – |
Q4 2017 | $22,000 | -60.0% | 10,665 | -11.1% | 0.00% | – |
Q3 2017 | $55,000 | +111.5% | 11,997 | +0.7% | 0.00% | – |
Q2 2017 | $26,000 | -36.6% | 11,916 | -9.0% | 0.00% | – |
Q1 2017 | $41,000 | +51.9% | 13,095 | +23.8% | 0.00% | – |
Q4 2016 | $27,000 | -34.1% | 10,580 | +0.3% | 0.00% | – |
Q3 2016 | $41,000 | +46.4% | 10,545 | +0.1% | 0.00% | – |
Q2 2016 | $28,000 | -78.9% | 10,531 | -19.0% | 0.00% | – |
Q2 2014 | $133,000 | -22.2% | 13,001 | -8.9% | 0.00% | – |
Q1 2014 | $171,000 | +26.7% | 14,272 | +19.8% | 0.00% | – |
Q4 2013 | $135,000 | +12.5% | 11,910 | +6.7% | 0.00% | – |
Q3 2013 | $120,000 | – | 11,167 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 6,574,060 | $25,376,000 | 1.97% |
SENZAR ASSET MANAGEMENT, LLC | 1,040,681 | $4,017,000 | 0.98% |
Cormorant Asset Management, LP | 850,000 | $3,281,000 | 0.51% |
Palo Alto Investors LP | 2,135,739 | $8,244,000 | 0.41% |
Opus Point Partners Management, LLC | 99,959 | $386,000 | 0.32% |
Granahan Investment Management | 1,527,837 | $5,897,000 | 0.17% |
WALL STREET ASSOCIATES | 367,200 | $1,417,000 | 0.13% |
CAXTON CORP | 21,870 | $84,000 | 0.10% |
SHEPHERD KAPLAN KROCHUK, LLC | 107,392 | $415,000 | 0.07% |
Joel Isaacson & Co., LLC | 70,660 | $273,000 | 0.07% |